Autor: |
Afzal, Raja Majid, Romme Christensen, Jeppe, Gynthersen, Rosa Maja Møhring, Lebech, Anne-Mette, Blinkenberg, Morten, Mens, Helene |
Předmět: |
|
Zdroj: |
Multiple Sclerosis Journal; Jul2024, Vol. 30 Issue 8, p1081-1083, 3p |
Abstrakt: |
Objective: To describe a case of neoehrlichiosis, an emerging opportunistic tick-borne infection, in a patient with multiple sclerosis (MS) treated with ocrelizumab. Methods: This is a case study. Results: Our patient developed clinical infection over several months while on ocrelizumab and was ultimately diagnosed with neoehrlichiosis, caused by the bacteria Neoehrlichia mikurensis. Resolution of symptoms began within a few days after the initiation of antibiotic treatment. Conclusion: We describe the first probable case of ocrelizumab-associated neoehrlichiosis in a patient with MS. Clinicians should be aware of this potentially debilitating and life-threatening infection in patients receiving CD20-depleting therapy. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|